Barnett Eva Renee

Chief Financial Officer

1 company

Good

Trades Analyzed

12M Win Rate

56.5%

Avg 3M Return

-1.8%

Avg 12M Return

-3.4%

Barnett Eva Renee is a Chief Financial Officer at Immunovant, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $11.5M based on current market prices.

Holdings by Company

IMVTApr 16, 2025

Current Shares396.8K

Value$11.48M

Net Activity-150,062

Bought: 0Sold: 150.1K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 16, 2025	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	2,993	$14.89	$44,565.77	-0.7%	+17.9%	-
Apr 9, 2025	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	11,063	$12.99	$143,708.37	-1.4%	+13.4%	+72.1%
Feb 19, 2025	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	2,814	$20.86	$58,700.04	-0.9%	-28.0%	+26.6%
Jan 15, 2025	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	2,298	$23.83	$54,756.80	-0.4%	-36.6%	+6.6%
Jan 8, 2025	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	4,105	$24.10	$98,930.50	-1.2%	-43.7%	+11.3%
Nov 20, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	4,174	$25.45	$106,228.30	-1.2%	-20.4%	-12.9%
Oct 16, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	3,271	$28.79	$94,172.09	-1.0%	-21.6%	-40.3%
Oct 9, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	5,162	$29.56	$152,588.72	-1.5%	-17.9%	-41.8%
Aug 21, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	3,768	$31.86	$120,044.64	-0.5%	-22.3%	-54.3%
Jul 17, 2024	IMVT Immunovant, Inc.	Chief Financial Officer	Sell	3,123	$29.69	$92,733.16	-0.4%	-4.8%	-39.0%